Results 41 to 50 of about 254,763 (308)

Partial depletion of plasminogen activator inhibitor‐1 decreases subcutaneous fat cell hypertrophy and liver cholesterol in high‐fat‐fed female mice

open access: yesFEBS Letters, EarlyView.
Obesity raises blood levels of PAI‐1, a protein linked to metabolic dysfunction‐associated steatotic liver disease in people with obesity. In female mice fed a high‐fat diet, partially lowering PAI‐1 led to smaller subcutaneous fat cells and lower liver cholesterol, without changing body weight or insulin sensitivity.
Claudia E. Ramirez Bustamante   +10 more
wiley   +1 more source

Longitudinal rotarod analysis of nestin-cre versus nestin-cre-MFN2T106M mutant mice.

open access: yes, 2016
The graphs show a longitudinal study, quantifying rotarod performance (secs) over a period of 75 days exclusive of an initial 12 day training period on the apparatus.
Jie Xu (34477)   +4 more
core   +1 more source

Normal Auditory Brainstem Response in DV-Cre and r4-Cre recombinase lines.

open access: yes, 2023
Audiograms from r4-Cre, Nkx2.2-Cre, Atoh1-Cre, Ptf1a-Cre mice. Auditory thresholds in Cre recombinase lines are comparable to Ctrl mice. Mean threshold ± SEM: 33.9 ± 0.8 dB SPL, 38.3 ± 1.4 dB SPL, 35 ± 2.5 dB SPL, 34.6 ± 0.8 dB SPL, 32.9 ± 2.3 dB SPL in ...
Jean-Luc Puel (3639409)   +7 more
core   +1 more source

Neutralization of the PTX3/CD44 axis suppresses TGF‐β1 signaling in kidney fibrosis

open access: yesFEBS Letters, EarlyView.
This study investigates how the PTX3/CD44 axis promotes kidney fibrosis by activating TGF‐β1 signaling. We demonstrate that the neutralizing antibody WHC‐001 effectively inhibits this pathway, suppressing myofibroblast activation and partial epithelial–mesenchymal transition (EMT).
Chao‐Chun Cheng   +8 more
wiley   +1 more source

CRE-DH Policy Lab Explainer

open access: yes, 2019
The Centre of Research Excellence in Disability and Health (CRE-DH) is funded by the National Health and Medical Research Council and is comprised of academics from 5 leading universities as well as an Advisory Group of stakeholders from the disability ...
HELEN DICKINSON (1105838)   +2 more
core   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Emx1-Cre and RGS9-Cre-mediated CB1-R knockout on the Nr4a1-eGFP background reveal the source of CB1-R in striosomes.

open access: yes, 2018
Fasciculation defects in the Emx1-Cre:CB1-Rf/f cross (A-C) illustrated with Fluoromyelin red (A, WT; B, Emx1-KO) and Sudan Black (C, Emx1-KO). CB1-R immunoreactivity was similar in striosomes in Emx1-Cre wildtype (D) and littermate Emx1-Cre;CB1-Rf/f ...
Jill R. Crittenden (237710)   +7 more
core   +1 more source

Educação Inclusiva da utopia a uma política educacional

open access: yesContexto & Educação, 2013
Este texto propõe uma reflexão sobre a Educação Inclusiva, que se apresenta como um novo paradigma educacional, a partir dos princípios estabelecidos pela Constituição Federal de 1988 e pela Lei de Diretrizes e Bases da Educação Nacional, Lei nº 9394/96.
Lenir Santos Schettert
doaj   +1 more source

Emergence of a Clinical Escherichia coli Sequence Type 131 Strain Carrying a Chromosomal blaKPC–2 Gene

open access: yesFrontiers in Microbiology, 2020
Objectives: Bacteria carrying the Klebsiella pneumoniae carbapenemase genes have rapidly spread worldwide and have become a great threat to public health. The blaKPC–2 gene has been primarily located on plasmids cocirculating in various strains. However,
Dairong Wang   +21 more
doaj   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy